Practical considerations for treating patients with cancer in the COVID-19 pandemic

Eva Segelov*, Craig Underhill, Hans Prenen, Christos Karapetis, Christopher Jackson, Louise Nott, Tim Clay, Nick Pavlakis, Sabe Sabesan, Ellen Heywood, Christopher Steer, Carrie Lethborg, Hui K. Gan, Desmond Yip, Narayan Karanth, Deme Karikios, C. Raina MacIntyre

*Corresponding author for this work

    Research output: Contribution to journalArticlepeer-review

    47 Citations (Scopus)

    Abstract

    Cancer has become a prevalent disease, affecting millions of new patients globally each year. The COVID-19 pandemic is having far-reaching impacts around the world, causing substantial disruptions to health and health care systems that are likely to last for a prolonged period. Early data have suggested that having cancer is a significant risk factor for mortality from severe COVID-19. A diverse group of medical oncologists met to formulate detailed practical advice on systemic anticancer treatments during this crisis. In the context of broad principles, issues including risks of treatment, principles of prioritizing resources, treatment of elderly patients, and psychosocial impact are discussed. Detailed treatment advice and options are given at a tumor stream level. We must maintain care for patients with cancer as best we can and recognize that COVID-19 poses a significant competing risk for death that changes conventional treatment paradigms.

    Original languageEnglish
    Pages (from-to)467-482
    Number of pages16
    JournalJCO Oncology Practice
    Volume16
    Issue number8
    DOIs
    Publication statusPublished - 2020

    Fingerprint

    Dive into the research topics of 'Practical considerations for treating patients with cancer in the COVID-19 pandemic'. Together they form a unique fingerprint.

    Cite this